ISS Session: Optimizing NF1 Tumor Management Across the Lifespan: Integrating Pain and Quality-of-Life Assessment into MEK Inhibitor and Surgical Decision-Making

31st Annual Meeting and Education Day of the Society for Neuro-Oncology · 13 November 2026 · 18:00–19:15 · 108 AB, First Floor, Convention Center

ISS Session: Optimizing NF1 Tumor Management Across the Lifespan: Integrating Pain and Quality-of-Life Assessment into MEK Inhibitor and Surgical Decision-Making was a session at 31st Annual Meeting and Education Day of the Society for Neuro-Oncology on 13 November 2026 in Philadelphia.